Coloplast A/S (CBHD) Stock Price & News

CBHD:ETR

Coloplast A/S

€64.78

+1.44%

(+0.92) 1D

Oct 30, 5:35:50 PM GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Next call in 3 days

Tue, Nov 3, 12:00 PM

Fiscal period

Q4 2026

- / DKK 5.73

Revenue / Est. (DKK)

- / 7.41B

Fiscal Q4 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in DKK

Loading Previous Earnings...

All values in DKK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	6.96B	7.04B	7.08B	7.36B
Cost of goods sold	2.20B	2.31B	2.37B	2.45B
Cost of revenue	2.20B	2.31B	2.37B	2.45B
Research and development expenses	249.00M	247.00M	254.00M	281.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.62B	2.64B	2.67B	2.72B
Operating expense	2.79B	2.88B	2.90B	2.98B
Total operating expenses	4.99B	5.19B	5.26B	5.43B
Operating income	1.97B	1.85B	1.82B	1.93B
Other non operating income	-6.00M	42.00M	-188.00M	-
EBT including unusual items	1.56B	1.79B	-1.24B	1.87B
EBT excluding unusual items	1.81B	1.83B	1.78B	1.89B
Income tax expense	680.00M	394.00M	-273.00M	412.00M
Effective tax rate	43.73%	22.00%	21.95%	21.98%
Other operating expenses	-80.00M	-6.00M	-23.00M	-25.00M
Net income	875.00M	1.40B	-971.00M	1.46B
Net profit margin	12.57%	19.84%	-13.71%	19.88%
Earnings per share	4.67	-	6.16	-
Interest and investment income	22.00M	32.00M	149.00M	169.00M
Interest expense	-152.00M	-164.00M	-	-206.00M
Net interest expenses	-130.00M	-132.00M	149.00M	-37.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	2.20B	2.20B	2.17B	2.29B
Gain or loss from assets sale	2.00M	-	1.00M	-5.00M

Finance